Cargando…

Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromers

Eluxadoline, an orally active mixed μ opioid receptor (μOR) agonist δ opioid receptor (δOR) antagonist developed for the treatment of diarrhea-predominant irritable bowel syndrome, normalizes gastrointestinal (GI) transit and defecation under conditions of novel environment stress or post-inflammato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujita, Wakako, Gomes, Ivone, Dove, Leonard S., Prohaska, David, McIntyre, Gail, Devi, Lakshmi A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769596/ https://www.ncbi.nlm.nih.gov/pubmed/25261794 http://dx.doi.org/10.1016/j.bcp.2014.09.015

Ejemplares similares

Evaluation of Eluxadoline Effect on Cardiac Repolarization
por: Bonifacio, Laura, et al.
Publicado: (2018)

Anti-Analgesic Effect of the Mu/Delta Opioid Receptor Heteromer Revealed by Ligand-Biased Antagonism
por: Milan-Lobo, Laura, et al.
Publicado: (2013)

Molecular Perspectives for mu/delta Opioid Receptor Heteromers as Distinct, Functional Receptors
por: Ong, Edmund W., et al.
Publicado: (2014)

Activation of the Mu-Delta Opioid Receptor Heteromers Blocks Morphine Rewarding Effects
por: Requana Aradas, Ariadna, et al.
Publicado: (2023)

An Emerging Role for the Delta Opioid Receptor in the Regulation of Mu Opioid Receptor Function
por: Rozenfeld, Raphael, et al.
Publicado: (2007)

Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist
por: Levy-Cooperman, N., et al.
Publicado: (2016)

Effect of Hepatic Impairment on Eluxadoline Pharmacokinetics
por: Marbury, Thomas C., et al.
Publicado: (2017)

Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and function
por: Gomes, Ivone, et al.
Publicado: (2014)

Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
por: Olson, Keith M., et al.
Publicado: (2023)

Effect of uptake transporters OAT3 and OATP1B1 and efflux transporter MRP2 on the pharmacokinetics of eluxadoline
por: Davenport, J Michael, et al.
Publicado: (2015)

Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use
por: Lacy, Brian E, et al.
Publicado: (2017)

The Possible Role of MOPr-DOPr Heteromers and Its Regulatory Protein RTP4 at Sensory Neurons in Relation to Pain Perception
por: Fujita, Wakako
Publicado: (2020)

Effects of treatment with eluxadoline on abdominal pain in patients with IBS‐D: Additional post hoc analyses of Phase 3 trials
por: Lembo, Anthony J., et al.
Publicado: (2020)

Heteromerization of Endogenous Mu and Delta Opioid Receptors Induces Ligand-Selective Co-Targeting to Lysosomes
por: Derouiche, Lyes, et al.
Publicado: (2020)

Investigation of Receptor Heteromers Using NanoBRET Ligand Binding
por: Johnstone, Elizabeth K. M., et al.
Publicado: (2021)

Impact of patient and disease characteristics on the efficacy and safety of eluxadoline for IBS-D: a subgroup analysis of phase III trials
por: Lacy, Brian E., et al.
Publicado: (2019)

Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships
por: Journigan, V. Blair, et al.
Publicado: (2017)

Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013)

Putative Kappa Opioid Heteromers As Targets for Developing Analgesics Free of Adverse Effects
por: Le Naour, Morgan, et al.
Publicado: (2014)

Activity of opioid ligands in cells expressing cloned mu opioid receptors
por: Gharagozlou, Parham, et al.
Publicado: (2003)

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Özdener, Ayşe Elif, et al.
Publicado: (2017)

Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs
por: Franco, Rafael, et al.
Publicado: (2023)

MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus Monkeys
por: Aceto, Mario D., et al.
Publicado: (2012)

Early response predicts a sustained response to eluxadoline in patients with irritable bowel syndrome with diarrhoea in two Phase 3 studies
por: Chey, W. D., et al.
Publicado: (2017)

Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea
por: Fragkos, Konstantinos C
Publicado: (2017)

Role of Mu and Delta Opioid Receptors in the Nucleus Accumbens in Cocaine-Seeking Behavior
por: Simmons, Diana, et al.
Publicado: (2009)

Functional Divergence of Delta and Mu Opioid Receptor Organization in CNS Pain Circuits
por: Wang, Dong, et al.
Publicado: (2018)

Kappa but not delta or mu opioid receptors form homodimers at low membrane densities
por: Cechova, Kristina, et al.
Publicado: (2021)

Compartment-specific opioid receptor signaling is selectively modulated by different dynorphin peptides
por: Kunselman, Jennifer M, et al.
Publicado: (2021)

Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Sobolewska-Włodarczyk, Aleksandra, et al.
Publicado: (2016)

New Insights on Expression and Function of Mu and Delta Opioid Receptors in Mouse Gastrointestinal Tract
por: Feng, Bin
Publicado: (2020)

Convergent, functionally independent signaling by mu and delta opioid receptors in hippocampal parvalbumin interneurons
por: He, Xinyi Jenny, et al.
Publicado: (2021)

Receptor and Channel Heteromers as Pain Targets
por: Berg, Kelly A., et al.
Publicado: (2012)

Heteromer Nanostars by Spontaneous Self-Assembly
por: Brocker, Caitlin, et al.
Publicado: (2017)

Discovery of the First Small-Molecule Opioid Pan Antagonist with Nanomolar Affinity at Mu, Delta, Kappa, and Nociceptin Opioid Receptors
por: Zaveri, Nurulain T., et al.
Publicado: (2015)

Heterodimerization of Mu Opioid Receptor Protomer with Dopamine D(2) Receptor Modulates Agonist-Induced Internalization of Mu Opioid Receptor
por: Vasudevan, Lakshmi, et al.
Publicado: (2019)

Mu and Delta Opioid Receptors Oppositely Regulate Motor Impulsivity in the Signaled Nose Poke Task
por: Olmstead, Mary C., et al.
Publicado: (2009)

Mu and Delta Opioid Receptors Are Coexpressed and Functionally Interact in the Enteric Nervous System of the Mouse Colon
por: DiCello, Jesse J., et al.
Publicado: (2019)

Distribution of delta and mu opioid receptor mRNA in rodent dorsal root ganglia neurons
por: Quirion, Béatrice, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_do9h861f007gala0rfk4v32fcq